Chemoinformaics analysis of Nitrotyrasanguinarine
| Molecular Weight | 498.491 | nRot | 4 |
| Heavy Atom Molecular Weight | 476.315 | nRig | 36 |
| Exact Molecular Weight | 498.143 | nRing | 7 |
| Solubility: LogS | -6.49 | nHRing | 3 |
| Solubility: LogP | 5.472 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 4 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 22 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 23 |
| nHA | 8 | APOL | 69.2434 |
| nHD | 1 | BPOL | 31.8906 |
| QED | 0.308 |
| Synth | 3.913 |
| Natural Product Likeliness | 0.7 |
| NR-PPAR-gamma | 0.032 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.012 |
| Pgp-sub | 0.002 |
| HIA | 0.002 |
| CACO-2 | -4.78 |
| MDCK | 0.0000326 |
| BBB | 0.025 |
| PPB | 0.997508 |
| VDSS | 0.37 |
| FU | 0.00671088 |
| CYP1A2-inh | 0.927 |
| CYP1A2-sub | 0.139 |
| CYP2c19-inh | 0.98 |
| CYP2c19-sub | 0.07 |
| CYP2c9-inh | 0.94 |
| CYP2c9-sub | 0.949 |
| CYP2d6-inh | 0.95 |
| CYP2d6-sub | 0.573 |
| CYP3a4-inh | 0.949 |
| CYP3a4-sub | 0.391 |
| CL | 17.215 |
| T12 | 0.077 |
| hERG | 0.085 |
| Ames | 0.935 |
| ROA | 0.294 |
| SkinSen | 0.198 |
| Carcinogencity | 0.948 |
| EI | 0.034 |
| Respiratory | 0.5 |
| NR-Aromatase | 0.756 |
| Antiviral | Yes |
| Prediction | 0.688201 |